Jan 24
|
AbbVie (ABBV) Stock Moves -0.22%: What You Should Know
|
Jan 24
|
Pharma Stock Roundup: JNJ's Q4 Earnings, FDA Nod to AZN, Daiichi Drug
|
Jan 24
|
Stocks to watch next week: ASML, Intel, LVMH, Shell and Glencore
|
Jan 24
|
AbbVie Inks a Deal With Neomorph for Molecular Glue Degraders
|
Jan 24
|
Is AbbVie Stock a Buy?
|
Jan 24
|
AbbVie and Neomorph link on oncology/immunology glue degraders
|
Jan 24
|
Allergan Aesthetics unveils new AA Signature Program and immersive booth at IMCAS World Congress 2025
|
Jan 23
|
Is AbbVie Inc. (ABBV) the Best Halal Dividend Stock to Invest In Now?
|
Jan 23
|
AbbVie Completes Acquisition of Nimble Therapeutics
|
Jan 23
|
AbbVie and Neomorph Announce Collaboration to Develop Molecular Glue Degraders for Oncology and Immunology
|
Jan 22
|
Why Is AbbVie Inc. (ABBV) Among the Best Large-Cap Value Stocks to Buy in 2025?
|
Jan 22
|
Is AbbVie Inc. (ABBV) the Best Stock to Invest In For Steady Dividends?
|
Jan 22
|
Downside risk from talc lawsuit, Stelara generic competition is 'manageable': JNJ CFO Joe Wolk
|
Jan 21
|
Got $1,500? 3 Healthcare Stocks to Buy and Hold Forever
|
Jan 21
|
Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere — Here's Why
|
Jan 21
|
Got $500? 2 Pharmaceutical Stocks to Buy and Hold Forever
|
Jan 21
|
3 Unstoppable Dividend-Growth Stocks Yielding More Than 3% That Income-Seeking Investors Want to Buy in 2025 and Hold Forever
|
Jan 20
|
AbbVie Inc. (ABBV): A Bull Case Theory
|
Jan 19
|
Top Wall Street Analyst Says Dump The Magnificent 7 And Go All In On These Three Big Pharma Dividend Stocks
|
Jan 18
|
Count on Dividend King Pepsi (PEP) for Stability in a Volatile Market
|